Therefore, we hypothesized that KLK1 plays a protective role in inflammatory bowel diseases (such as ulcerative colitis) by maintaining intestinal epithelial barrier function, and its downregulation may lead to intestinal barrier damage, thereby promoting the development of inflammation and the transformation process of colon cancer. This evidence concerns the gene KLK1 and malignant colon neoplasm.